PL1748063T3 - Wytwarzanie i oczyszczanie Białka A bez zastosowania składników pochodzenia zwierzęcego - Google Patents

Wytwarzanie i oczyszczanie Białka A bez zastosowania składników pochodzenia zwierzęcego

Info

Publication number
PL1748063T3
PL1748063T3 PL06253985T PL06253985T PL1748063T3 PL 1748063 T3 PL1748063 T3 PL 1748063T3 PL 06253985 T PL06253985 T PL 06253985T PL 06253985 T PL06253985 T PL 06253985T PL 1748063 T3 PL1748063 T3 PL 1748063T3
Authority
PL
Poland
Prior art keywords
ingredients
purification
protein
production
animal origin
Prior art date
Application number
PL06253985T
Other languages
English (en)
Polish (pl)
Inventor
Thomas Richard Leary
Daniel Lafoe
Original Assignee
Avantor Performance Mat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantor Performance Mat Inc filed Critical Avantor Performance Mat Inc
Publication of PL1748063T3 publication Critical patent/PL1748063T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL06253985T 2005-07-29 2006-07-31 Wytwarzanie i oczyszczanie Białka A bez zastosowania składników pochodzenia zwierzęcego PL1748063T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/194,093 US7375188B2 (en) 2005-07-29 2005-07-29 Vegetarian protein a preparation and methods thereof
EP06253985A EP1748063B1 (en) 2005-07-29 2006-07-31 Protein A production and purification without using animal derived components

Publications (1)

Publication Number Publication Date
PL1748063T3 true PL1748063T3 (pl) 2012-11-30

Family

ID=36954658

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06253985T PL1748063T3 (pl) 2005-07-29 2006-07-31 Wytwarzanie i oczyszczanie Białka A bez zastosowania składników pochodzenia zwierzęcego

Country Status (5)

Country Link
US (2) US7375188B2 (enExample)
EP (1) EP1748063B1 (enExample)
JP (1) JP2007039454A (enExample)
ES (1) ES2389775T3 (enExample)
PL (1) PL1748063T3 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY185597A (en) * 2005-09-20 2021-05-24 Avantor Performance Mat Inc Vegetarian protein a preparation and methods thereof
WO2008109667A2 (en) 2007-03-05 2008-09-12 Om Pharma Bacterial extract for digestive or urinary tract disorders and process for its preparation
ES2366941T3 (es) * 2008-08-28 2011-10-26 Novartis Ag Producción de escualeno a partir de levaduras hiperproductoras.
DK2814514T3 (en) 2012-02-16 2017-12-18 Atyr Pharma Inc Histidyl tRNA synthetases for the treatment of autoimmune and inflammatory diseases
ES2847383T3 (es) 2013-03-15 2021-08-03 Atyr Pharma Inc Conjugados de Fc-histidil-ARNt sintetasa
JP6404821B2 (ja) * 2013-09-12 2018-10-17 国立大学法人 岡山大学 インターロイキン１０産生促進剤
EP3612215B1 (en) 2017-04-20 2024-08-28 aTyr Pharma, Inc. Compositions for treating lung inflammation
CN106977591B (zh) * 2017-05-04 2020-05-05 广州康盛生物科技股份有限公司 一种分离纯化重组葡萄球菌蛋白a的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3625833A (en) 1970-01-23 1971-12-07 James J Schaffer Process for producing antiviral substance from staphylococcus organisms
US4464165A (en) 1980-11-24 1984-08-07 American Hoechst Corporation Material and method for removing immunoglobulins from whole blood
US5151350A (en) 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
US4699783A (en) 1983-03-11 1987-10-13 Terman David S Products and methods for treatment of cancer
US4617266A (en) 1983-04-28 1986-10-14 Genex Corporation Production of Protein A
JPS61224997A (ja) 1985-03-29 1986-10-06 Chemo Sero Therapeut Res Inst プロテインａの精製方法
US4801687A (en) 1986-10-27 1989-01-31 Bioprobe International, Inc. Monoclonal antibody purification process using protein A
EP0289129A3 (en) 1987-03-26 1990-10-10 Repligen Corporation High purity protein a preparation
ATE91152T1 (de) 1988-07-22 1993-07-15 Imre Corp Gereinigte protein a-zusammensetzungen und verfahren zu ihrer herstellung.
WO1999010370A1 (en) * 1997-08-25 1999-03-04 Torres Anthony R A simple, environmentally benign, method for purifying protein a
US5902722A (en) * 1997-12-05 1999-05-11 The Perkin-Elmer Corporation Method of detecting organisms in a sample
US6406909B1 (en) * 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
PL374311A1 (en) 2001-12-21 2005-10-03 Immunex Corporation Methods for purifying protein
US20040235139A1 (en) * 2002-12-23 2004-11-25 Demain Arnold L. Clostridium difficile culture and toxin production methods
CA2546769A1 (en) * 2003-12-12 2005-06-23 Sanofi Pasteur Limited Production of diphtheria toxin
US20050282294A1 (en) 2004-06-17 2005-12-22 Lothar Britsch Affinity supports with immobilised protein A
MY185597A (en) * 2005-09-20 2021-05-24 Avantor Performance Mat Inc Vegetarian protein a preparation and methods thereof

Also Published As

Publication number Publication date
EP1748063A1 (en) 2007-01-31
EP1748063B1 (en) 2012-06-27
JP2007039454A (ja) 2007-02-15
US20090060904A1 (en) 2009-03-05
US7375188B2 (en) 2008-05-20
US20070026489A1 (en) 2007-02-01
ES2389775T3 (es) 2012-10-31

Similar Documents

Publication Publication Date Title
UA94221C2 (en) Lipocalin protein
HRP20161230T1 (hr) Aerosolizirani fluorokinoloni i njihova uporaba
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
CR9878A (es) Tratamiento y profilaxis de microangiopatias
BRPI0714539A2 (pt) "formas farmacêuticas"
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
DE112006002352A5 (de) Stabförmiger Körper
EP1968649A4 (en) NANOPARTICLES OF PROTEINS AND THEIR USE
DK1863899T3 (da) Hudbehandlingspræparater
FI7535U1 (fi) Saniteettituote
EP1886090A4 (en) TREE HARVESTING DEVICE
EP1965827A4 (en) TREATMENT OF CONDITIONS RELATED TO DEMYELINATION
EP1644540A4 (en) HIGH-STRENGTH ANTICORROSION CONSTRUCTION STEELS REINFORCED BY NANO-PRECIPITATION
HRP20150320T1 (xx) Formulacije i metode za lijeäśenje amiloidoze
ATE523092T1 (de) Pflanzenproteinpellets
PL1748063T3 (pl) Wytwarzanie i oczyszczanie Białka A bez zastosowania składników pochodzenia zwierzęcego
PT1763520E (pt) Utilização de benzopiranonas trissubstituídas
DE602005006105D1 (de) Membrankörper und entsprechendes herstellungsverfahren
EP2043776A4 (en) PREPARATION OF MONOLITHIC ARTICLES
DE602006007982D1 (de) Modular-indikations-sicherungshalter
BRPI0719997A2 (pt) Uso de epotilonas no tratamento de osteoporose e doenças relacionadas
ITMI20050245A1 (it) Composto di origine animale ozonizzato
FI20055672L (fi) Sauvan tassu
ITBO20050375A1 (it) Riunito dentale
ATE377058T1 (de) Pflegemittel